The preclinical trials of FLOWMAKER®, at the Heart Failure 2023 Congress in Prague and the ISHLT in Denver.
FineHeart has completed a tour of the major international cardiology congresses, where we presented our abstract demonstrating the potential of sustained myocardial recovery. Prof. Finn Gustafsson, professor of severe heart failure and transplantation at the cardiology department of the Copenhagen Heart Centre, and Prof. Laurent Barandon, Director of the cardiology department of St-Augustin clinic in Bordeaux, presented the exceptional results of the preclinical trials of FLOWMAKER®, at the Heart Failure Congress in Prague and the ISHLT in Denver, respectively.